Aarkstore.com announces, The Latest market research report is available inits vast collection:Cataract – Pipeline Review, H1 2012You can also request for sample page of above mention reports email@example.comSummaryGlobal Markets Direct’s, Cataract - Pipeline Review, H1 2012, provides an overviewof the Cataract therapeutic pipeline. This report provides information on thetherapeutic development for Cataract, complete with latest updates, and specialfeatures on late-stage and discontinued projects. It also reviews key playersinvolved in the therapeutic development for Cataract. Cataract - Pipeline Review, H12012 is built using data and information sourced from Global Markets Direct’sproprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Cataract.- A review of the Cataract products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.
Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Cataract Overview 6Therapeutics Development 7An Overview of Pipeline Products for Cataract 7Cataract Therapeutics under Development by Companies 9Mid Clinical Stage Products 10Comparative Analysis 10Pre-Clinical Stage Products 11Comparative Analysis 11Cataract Therapeutics – Products under Development by Companies 12Companies Involved in Cataract Therapeutics Development 13InSite Vision Incorporated 13R-Tech Ueno, Ltd. 14NovaLead Pharma Pvt. Ltd. 15Omeros Corporation 16ESBATech AG 17Cataract – Therapeutics Assessment 18Assessment by Monotherapy Products 18Assessment by Route of Administration 19Assessment by Molecule Type 21Drug Profiles 23BromSite - Drug Profile 23Product Description 23Mechanism of Action 23R&D Progress 23ESBA 105 - Drug Profile 24Product Description 24Mechanism of Action 24R&D Progress 24Bendavia - Drug Profile 26
Product Description 26List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H12012&PubId=&pagenum=1Hereditary Angioedema (HAE) – Pipeline Review, H1 2012Cataract – Pipeline Review, H1 2012Neurofibromatoses – Pipeline Review, H1 2012Viral Conjunctivitis – Pipeline Review, H1 2012Fistula – Pipeline Review, H1 2012Onchocerciasis (River Blindness) – Pipeline Review, H1 2012Seborrhea – Pipeline Review, H1 2012Cerebral Palsy – Pipeline Review, H1 2012Hemolytic Disease In Newborns – Pipeline Review, H1 2012
Panic Disorders – Pipeline Review, H1 20124SC AG – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: firstname.lastname@example.org